Vascular Pharmacology

Print ISSN
1537-1891
Electronic ISSN
1879-3649
Impact factor
2.174
Publisher
Sciencedirect
URL
http://www.sciencedirect.com/science/journal/15371891
Usage rank
4675
Article count
4354
Free count
8
Free percentage
0.00183739
PDFs via platforms
Rcgp, Gale, Sciencedirect, and Ingenta

  1. Inside front cover (editorial board members)
    Author(s) unavailable

    Vascular Pharmacology 73:IFC (2015)

  2. Graphical abstracts contents listing
    Author(s) unavailable

    Vascular Pharmacology 73:e1 (2015)

  3. Ultra-fast PubMed accessibility of accepted papers — A new feature of Vascular Pharmacology for the authors

    Vascular Pharmacology 67-69:1 (2015)

  4. Graphical abstracts contents listing
    Author(s) unavailable

    Vascular Pharmacology 67-69:e1 (2015)

  5. Editorial Board
    Author(s) unavailable

    Vascular Pharmacology 67-69:IFC (2015)

  6. Graphical abstracts
    Author(s) unavailable

    Vascular Pharmacology 64:e1 (2015)

  7. Editorial Board
    Author(s) unavailable

    Vascular Pharmacology 64:IFC (2015)

  8. Graphical abstracts contents listing
    Author(s) unavailable

    Vascular Pharmacology 63(3):e1 (2014)

  9. Editorial Board
    Author(s) unavailable

    Vascular Pharmacology 63(3):IFC (2014)

  10. Editorial Board
    Author(s) unavailable

    Vascular Pharmacology 63(2):IFC (2014)

  11. Notch signal integration in the vasculature during remodeling

    Vascular Pharmacology 63(2):97 (2014)

    Notch signaling plays many important roles in homeostasis and remodeling in the vessel wall, and serves a critical role in the communication between endothelial cells and smooth muscle cells. Within blood vessels, Notch signaling integrates with multiple pathways by mechanisms includin...
  12. Graphical abstracts contents listing
    Author(s) unavailable

    Vascular Pharmacology 63(2):e1 (2014)

  13. Disturbance of vasodilation via protease-activated receptor 2 in SHRSP.Z-Leprfa/IzmDmcr rats with metabolic syndrome

    Vascular Pharmacology 63(1):46 (2014) PMID 25109437

    Protease-activated receptor-2 (PAR2) activation causes vascular inflammation and vasodilation, but its role in metabolic syndrome (MetS) remains uncertain. Therefore, we examined whether the PAR2-induced vasodilation of SHRSP.Z-Leprfa/IzmDmcr rats (SHRSP.ZF) is impaired and if so, whet...
  14. Sulforaphane inhibits endothelial protein C receptor shedding in vitro and in vivo

    Vascular Pharmacology 63(1):13 (2014) PMID 25016099

    Sulforaphane (SFN), a natural isothiocyanate present in cruciferous vegetables such as broccoli and cabbage, is effective in preventing carcinogenesis, diabetes, and inflammatory responses. Increasing evidence has demonstrated that beyond its role in the activation of protein C, endoth...
  15. Editorial Board
    Author(s) unavailable

    Vascular Pharmacology 63(1):IFC (2014)

  16. Graphical abstracts contents listing
    Author(s) unavailable

    Vascular Pharmacology 63(1):e1 (2014)

  17. Role of 5-HT7 receptors in the inhibition of the vasodepressor sensory CGRPergic outflow in pithed rats

    Vascular Pharmacology 63(1):4 (2014) PMID 25179247

    The role of calcitonin gene-related peptide (CGRP) in the modulation of vascular tone has been widely documented. Indeed, electrical stimulation of the perivascular sensory outflow in pithed rats induces vasodepressor responses by activation of CGRP receptors. This study investigated t...
  18. Reprint of "Alteration of endothelial proteoglycan and heparanase gene expression by high glucose, insulin and heparin"

    Vascular Pharmacology 62(3):113 (2014)

    Heparan sulfate proteoglycans (HSPGs) contain a core protein with glycosaminoglycans attached. Reduced glycosaminoglycan, in endothelial HSPGs syndecan and perlecan, is associated with diabetic cardiovascular complications but changes in core protein remain controversial. Since heparan...
  19. Editorial Board
    Author(s) unavailable

    Vascular Pharmacology 62(3):IFC (2014)

  20. Graphical abstracts contents listing
    Author(s) unavailable

    Vascular Pharmacology 62(3):e1 (2014)